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1. Introduction 
The plasma membrane contains some enzymes 
whose active sites face the external medium rather 
than the cytoplasm, and these enzymes have been 
called ‘ectoenzymes’ [ 1,2]. The biological function of 
an ectoenzyme can thus be explored by treatment of 
intact cells with impermeant reagents which inacti- 
vate the enzyme. Determination of the time course of 
return of the catalytic activity to steady state after 
irreversible inhibition has considerable potential for 
providing information on the biosynthesis and turn- 
over of these specific plasma membrane proteins [3]. 
However, the lack of suitable irreversible inhibitors 
has limited the use of these methods for the study of 
plasma membrane proteins. 
dase. The enzyme is not reactivated by subsequent 
reaction with sodium borohydride. The periodate 
treatment has no effect on 2 other glycoprotein ecto- 
enzymes, 5’-nucleotidase and alkaline phosphodiester- 
ase I, or on alkaline phosphatase, leucine-fl-napthyl- 
amidase, and N-acetyl-fl-glucosaminidase. 
2. Materials and methods 
y-Glutamyltranspeptidase (EC 2.3.2.2) is a glyco- 
protein ectoenzyme which is widely distributed in 
mammalian tissues and which catalyses the transfer 
of the y-glutamyl group of glutathione to certain 
L-amino acids and peptides [4,5]. In addition to its 
role in glutathione metabolism a number of functions 
have been postulated for the enzyme including mer- 
capturate biosynthesis, ammoniagenesis and amino 
acid transport [5]. It is not yet clear whether the 
enzyme plays a physiological role in any of these lat- 
ter processes. 
Adult, male rats of the inbred Lewis strain were 
obtained from Microbiological Assoc. (Bethesda 
MD). Hanks’ balanced salt solution (HBSS) and phos- 
phate-buffered saline (PBS) were from Grand Island 
Biological Co. (Grand Island NY). Vibrio cholerue 
neuraminidase (EC 3.2.1 .I 8) was from Calbiochem 
(San Diego CA). Dactylium dendroides galactose oxi- 
dase (EC 1 .1.3.9), obtained from Worthington Bio- 
chemical Corp. (Freehold NJ) was purified before use 
on Sepharose 6B [6] and assayed as in [7]. Sodium 
periodate was from Matheson, Coleman and Bell 
(Norwood OH) and sodium borohydride and all 
enzyme substrates were from Sigma Chemical Co. 
(St Louis MO). 
Treatment of intact rat lymph node cells with low 
concentrations of sodium periodate is shown here to 
lead to complete inhibition of r-glutamyltranspepti-’ 
Cervical and mesenteric lymph nodes of 3 rats 
were removed, rinsed in HBSS and forced through a 
stainless steel screen. The resulting cell suspension 
was filtered through cotton to remove large debris 
and the cells were washed twice by centrifugation 
(375 X g, 10 min) and resuspension in HBSS. 
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For enzyme treatment the cells were resuspended 
in HBSS at 2 X lO’/ml. Neuraminidase and galactose 
oxidase were added to give final concentrations of 15 
and 2.5 units/ml, respectively, and the suspension was 
incubated at 37°C for 30 min. The cells were then 
centrifuged and resuspended in HBSS. 
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For periodate treatment the cells were resuspended 
at 2 X lO’/ml in PBS and an equal volume of a 
freshly prepared solution of ice-cold 2.4 mM sodium 
periodate in PBS was added. The mixture was incu- 
bated for 15 min on ice, centrifuged and the cells 
resuspended in HBSS. 
Oxidized cells were reacted with sodium boro- 
hydride by resuspending them at 2 X 1 O’/ml in PBS 
and adding an equal volume of freshly prepared 
NaBH4 in PBS. The suspension was incubated for 
30 min on ice and then centrifuged and the cells 
washed once in HBSS. 
The cells were finally resuspended in 0.15 M KCl, 
the suspension was divided into portions for the 
enzyme assays, and they were frozen and thawed 
once to lyse the cells. 
The number of cells in the various suspensions was 
determined with the model ZBI Coulter counter 
(Coulter Electronics Inc., Hialeah FL,). 
y-Glutamyltranspeptidase [8], alkaline phospho- 
diesterase I [9], alkaline p-nitrophenylphosphatase 
[ 91 and N-acetyl-f3glucosaminidase [lo] were deter- 
mined by the indicated calorimetric procedures. L.eu- 
tine-fl-naphthylamidase was assayed fluorometrically as 
in [ 111. 5’-Nucleotidase was assayed by calorimetric 
determination of Pi [12] released from AMP [13]. 
Under the conditions of the assays all activities dis- 
played linearity with respect to both incubation time 
and the quantity of lymph node cell lysate. Enzyme 
activities are expressed in units of I.tmol/min. 
3. Results and discussion 
Treatment of intact lymphocytes with neuramin- 
idase and galactose oxidase introduces aldehyde func- 
tions at the C-6 position of terminal and penultimate 
galactose (and N-acetylgalactosamine) residues on cell 
surface glycosylated molecules [ 14-161. Low con- 
centrations of periodate generate aldehydes at the 
exocyclic carbons of terminal sialic acid residues of 
the same or similar molecules [ 16,171. The chemical 
reagent, as opposed to the enzymatic treatment, 
probably also covalently reacts with other oxidizable 
functional groups on cell membrane molecules. Treat- 
ments of rat lymph node cells with periodate or with 
neuraminidase plus galactose oxidase are not cyto- 
toxic and, in fact, if the modified cells are cultured 
they undergo mitogenesis [ 161. 
In table 1 we show the effects of periodate or 
neuraminidase plus galactose oxidase treatments on 
the activity of a number of lymphocyte enzymes. 
Three of these enzymes, y-glutamyltranspeptidase, 
5’nucleotidase and alkaline phosphodiesterase I are 
known to be plasma membrane ectoenzymes on the 
basis of subcellular fractionation [18,19], cytochem- 
Table 1 
Effects of neuraminidase and galactose oxidase or periodate treatments on rat 
lymphocyte enzymes 
Enzyme Activity (mU/109 cells) 
Untreateda NGOb PeriodateC 
yGlutamyltranspeptidase 131 f 25 130+ 24 4~ 6 
5’-Nucleotidase 431 + 61 312 c 65 358 f 32 
Alkaline phosphodiesterase 1 1165 * 16 1584 f 324 1141 f 348 
Alkaline phosphatase 454 * 93 393 f 69 461 f 152 
Leucine+naphtylamidase 330+48 341 f 60 329 * 43 
N-Acetyl-p-glucosaminidase 192*45 162t 22 140+- 21 
a Represents mean t SD for 3 samples of control cells from same cell preparation: 
1 sample was set aside after preparation, 1 was subjected to a mock neuraminid- 
ase + galactose oxidase treatment, and 1 was subjected to a mock periodate 
treatment 
b All cells were treated with neuraminidase plus galactose oxidase as in the text. 
They were then divided into 4 portions and treated with 0, 0.1, 1 .O or 10 mM 
NaBH,; number represents mean * SD for these 4 samples 
c Same as in b except that cells were initially treated with periodate as described 
in text 
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istry [20,21] and enzyme inactivation [20,22-251 
studies. All 3 enzymes are sialoglycoproteins. Alka- 
line phosphatase and leucine+naphthylamidase of rat 
lymph node cells are partly soluble (2/3rds) and partly 
associated with the plasma membrane (E. H. H., 
unpublished). It is not known whether these enzymes 
are ectoenzymes or glycoproteins. N-Acetyl$-glucos- 
aminidase is an intracellular, lysosomal acid hydrolase 
that is a glycoprotein [26]. Of the 6 enzymes studied, 
treatment of intact cells with periodate or with neur- 
aminidase plus galactose oxidase had no effect on 
their activity with one striking exception: periodate 
treatment completely inhibited the cell surface y-glu- 
tamyltranspeptidase. This inhibition was not reversed 
by subsequent treatment with up to 10 mM sodium 
borohydride, conditions under which all of the perio- 
date generated aldehydes on cell surface sialic acid 
residues are reduced to alcohols [ 161. Our observa- 
tion that treatment of intact cells with neuraminidase 
plus galactose oxidase has no effect on the activity of 
y-glutamyltranspeptidase agrees with observations 
[27] that treatment of the purified enzyme with 
neuraminidase alone does not effect the catalytic 
activity. 
The fact that periodate treatment completely and 
irreversibly inactivates y-glutamyltranspeptidase while 
treatment with neuraminidase plus galactose oxidase 
has no effect immediately raises the question of the 
chemical mechanism of periodate inactivation. In the 
absence of detailed structural analyses it is, of course, 
impossible to explain our results in chemical terms. 
However, considering the study [ 161 on cell surface 
glycoproteins of rat lymph node cells, we can suggest 
one possibility. When cells are oxidized with perio- 
date and treated with [3H] borohydride, 4 labeled 
glycoproteins can be seen on subsequent SDS gel elec- 
trophoresis which are not labeled if lymph node cells 
are oxidized by neuraminidase plus galactose oxidase; 
these are in addition to -20 components labeled in 
common after either method of oxidation. These 
‘periodate specific’ glycoproteins may contain 4-O- 
acylated sialic acids which are resistant to neuramin- 
idase but susceptible to periodate [28,29]. Two such 
glycoproteins on lymph node cells have M,-values of 
-28 000 and 30 000 which are near that of the small, 
catalytic subunit of rat y-glutamyltranspeptidase 
[21]; one of these is sensitive to papain. Another 
lymph node cell glycoprotein that can be labeled 
after either periodate or neuraminidase plus galactose 
oxidase treatment has app. M, - 70 000 and is sensi- 
tive to treatment with papain, properties of the large 
subunit of the enzyme [21]. Thus, it is possible that 
inactivation of y-glutamyltranspeptidase by periodate 
is due to the presence of periodate-susceptible but 
neuraminidase-resistant sialic acids on the catalytic 
subunit of the enzyme. 
Regardless of the mechanism of inactivation of 
y-glutamyltranspeptidase by periodate, the phenom- 
enon may offer useful approaches to questions con- 
cerning the biosynthesis and function of the enzyme. 
The fact that periodate specifically inactivates y-glu- 
tamyltranspeptidase but not other ectoenzymes sug- 
gests that it could be used to study the turnover of 
y-glutamyltranspeptidase, as has been done for other 
cell surface enzymes using more broadly reactive 
reagents such as the diazonium salt of sulfanilic acid 
[24,25]. Finally, by completely inhibiting y-glutamyl- 
transpeptidase in intact cells, periodate may have 
advantages over other compounds such as the 6-diazo- 
S-oxo-Lnorleucine which will largely but not com- 
pletely inhibit the enzyme in intact cells [23]. This 
would be especially important for experiments on 
proposed transpeptidase functions where it is often 
difficult to interpret the results when there is 1 O-20% 
residual enzyme activity after inhibition. 
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